The company's profit before tax stood at Rs 45.81 crore in Q2FY24 as compared to pre-tax loss of Rs 27 crore recorded in corresponding quarter last year.

The company's Poultry and Poultry Products segment reported revenue to Rs 426.19 crore, up 3.2% YoY, due to improvement in realisations from the sale of day old chicks and grown up broilers; and also due to lower cost of feed ingredients i.e. maize and soya.

The Oilseed segment reported revenue of Rs 436.15 crore, down 13.17% YoY and down 10.68% QoQ While the Animal Health Products segment reported revenue of Rs 75.16 crore, up 1.71% YoY and down 4.93% QoQ.

Earlier, the company had announced setting up of new manufacturing unit at Village, Kesurdi, Taluka Khandala, district, Satara, Maharashtra under its animal health product division in December 2021. The project is on track and construction activities are completed. The company is an advanced stage for obtaining necessary licenses for operations and it is expected that the commercial production will commence in December, 2023.

Venkys (India) is the largest fully integrated poultry group in Asia. Its diversified products include SPF eggs, chicken and eggs processing, broiler and layer breeding, genetic research and Poultry diseases diagnostic, Poultry vaccines and feed supplements, vaccine pro.